Supply Chain Intelligence

Collegium Pharmaceutical, Inc. Supply Chain

COLL supply chain intelligence for Collegium Pharmaceutical, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

COLL ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
2Customers
3Debt Items
20Related Chains

Collegium Pharmaceutical, Inc. Suppliers

TickerNameConfidenceEvidence
HALO-PHARMACEUTICAL-INC HALO-PHARMACEUTICAL-INC 92% Nucynta IR is manufactured by Halo Pharmaceutical, Inc. in Whippany, New Jersey.
PATHEON PATHEON 92% Nucynta ER is currently manufactured by Patheon in Cincinnati, Ohio.
SHARP-PACKAGING-SOLUTIONS SHARP-PACKAGING-SOLUTIONS 92% Symproic is manufactured by UPM Pharmaceuticals in Bristol, Tennessee and packaged by Sharp Packaging Solutions in Allentown, Pennsylvania.
UPM-PHARMACEUTICALS UPM-PHARMACEUTICALS 92% Symproic is manufactured by UPM Pharmaceuticals in Bristol, Tennessee.

Collegium Pharmaceutical, Inc. Customers

TickerNameConfidenceEvidence
BIOPHARMA-CREDIT-PLC BIOPHARMA-CREDIT-PLC 62% d payors are subject to applicable anti-kickback, fraud and abuse, transparency, and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, exclusion fro…
BPCR-LIMITED BPCR-LIMITED 62% d payors are subject to applicable anti-kickback, fraud and abuse, transparency, and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, exclusion fro…

Collegium Pharmaceutical, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
COLL-DEBT-8791 Warrants outstanding: 2445 90% xbrl warrant detail from xbrl 2018-12-31.
COLL-DEBT-8792 Xbrl Convertible 90% xbrl convertible detail from xbrl 2026-03-31.
COLL-DEBT Debt stack $929.7M 90% Market cache reports total debt of $929.7M.

Collegium Pharmaceutical, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Collegium Pharmaceutical, Inc..

Collegium Pharmaceutical, Inc. Ownership

HolderNameConfidenceEvidence
COLL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 270 tracked holders.

Collegium Pharmaceutical, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BMY Bristol-Myers Squibb Company 100.00 2
HLNCF Haleon plc 100.00 2
AARD Aardvark Therapeutics, Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
CRSP CRISPR Therapeutics AG 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
A Agilent Technologies, Inc. 100.00 2
ABT Abbott Laboratories 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
SLGL Sol-Gel Technologies Ltd. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
DVLT Datavault AI Inc. 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
View COLL supply chain intel →

Explore the full interactive supply chain map for Collegium Pharmaceutical, Inc..

Open COLL supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map